After Setbacks, Eurand Has Zenpep In Its Step

A year after FDA approval, Eurand's Zenpep pancreatic enzyme therapy is rapidly gaining traction, and its manufacturer is looking for in-licensing opportunities in the U.S. in GI, cystic fibrosis, and orphan diseases.